Global CRISPR Market : Market Analysis by Knowledge Sourcing Intelligence
The global CRISPR market was valued at US$551.242 million in 2017 and is expected to grow at a CAGR of 33.26% to reach a total market size of US$3,086.697 million in 2023. CRISPR is one of the most popular tools for genome editing or engineering. This method utilizes a modified bacterial protein and RNA to facilitate DNA sequences alteration and gene function modification. Unparalleled control over genes offered by this tool has been increasing its popularity among researchers. Ongoing research in rare and orphan diseases and huge investments being pumped by market players into them are boosting the growth of the market. However, ethical concerns associated with genome editing have been restraining the market growth to some extent.
Global CRISPR market by Geography :
The global CRISPR market was valued at US$551.242 million in 2017 and is expected to grow at a CAGR of 33.26% to reach a total market size of US$3,086.697 million in 2023. CRISPR is one of the most popular tools for genome editing or engineering. This method utilizes a modified bacterial protein and RNA to facilitate DNA sequences alteration and gene function modification. Unparalleled control over genes offered by this tool has been increasing its popularity among researchers. Ongoing research in rare and orphan diseases and huge investments being pumped by market players into them are boosting the growth of the market. However, ethical concerns associated with genome editing have been restraining the market growth to some extent.The market research provides a detailed analysis of the global CRISPR Market on the basis of various segment like- By Region, By Applications etc.Global CRISPR market Share by Region |
By applications, the CRISPR market is segmented as genome editing, genetic engineering, GMO and crops, human stem cells, and others. Genome editing and genetic engineering hold significant market share owing to rising R&D investment in drug discovery and pre-clinical trials to devleop drugs for rare and orphan diseases. GMO and crops segment will witness a signifcant CAGR during the forecast period on account of rising demand for genetically-modified crops.
Request Free Sample or Download the report:
For our Healthcare industry coverage:
Rising prevalence of rare and orphan diseases is significantly boosting the research activities using gene editing technologies including worldwide. International organizations as well as international and domestic banks and financial institutions are funding global healthcare and pharmaceutical companies to continue the R&D processes for the development of cures and treatments for orphan and rare diseases.
Comments
Post a Comment